Apellis Pharmaceuticals, Inc. (APLS) NASDAQ
40.70
+0.07(+0.17%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
40.70
+0.07(+0.17%)
Currency In USD
| Market Cap | 3.17B |
| Enterprise Value | 3.18B |
| P/E Ratio | 229.1 |
| PEG Ratio | -4.45 |
| Price/Sales Ratio | 5.18 |
| Price/Book Ratio | 13.86 |
| Enterprise/Revenue | 5.2 |
| Enterprise/EBITDA | 74.59 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.02 |
| Operating Margin | 0.06 |
| Return On Assets | 0.02 |
| Return On Equity | 0.08 |
| Revenue | 1B |
| Revenue/Share | 7.97 |
| Gross Profit | 901.55M |
| EBITDA | 70M |
| Net Income | 22.39M |
| Diluted EPS | 0.18 |
| Total Cash | 467.76M |
| Total Cash/Share | 3.71 |
| Total Debt | 486.31M |
| Total Debt/Equity | 1.31 |
| Current Ratio | 3.14 |
| Book Value Per Share | 2.94 |
| 52-Week Change | 105.56 |
| 52-Week High | 40.77 |
| 52-Week Low | 16.1 |
| Moving Average 50 Days | 22.25 |
| Moving Average 200 Days | 22.87 |
| Average Volume | 4.95M |
| Shares Outstanding | 127.83M |
| % Held by Institutions | 100.29 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |